{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:55:48Z","timestamp":1786982148964,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2000,12,1]],"date-time":"2000-12-01T00:00:00Z","timestamp":975628800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Gastro"],"published-print":{"date-parts":[[2000,12]]},"DOI":"10.1007\/s11938-000-0033-8","type":"journal-article","created":{"date-parts":[[2007,6,3]],"date-time":"2007-06-03T13:44:12Z","timestamp":1180878252000},"page":"451-456","source":"Crossref","is-referenced-by-count":10,"title":["Alphain1-antitrypsin deficiency"],"prefix":"10.1007","volume":"3","author":[{"given":"David H.","family":"Perlmutter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"33_CR1","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJM197606102942404","volume":"294","author":"T Sveger","year":"1976","unstructured":"Sveger T: Liver disease in \u03b11-antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med 1976, 294:1216\u20131221. Description of the most important prospective and unbiased study of the incidence and severity of liver disease in \u03b11-AT deficiency.","journal-title":"N Engl J Med"},{"key":"33_CR2","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1164\/ajrccm\/140.4.961","volume":"140","author":"EK Silverman","year":"1989","unstructured":"Silverman EK, Miletich JP, Pierce JA, et al.: Alpha-1-antitrypsin deficiency: prevalence estimation from direct population screening. Am Rev Respir Dis 1989, 140:961\u2013966.","journal-title":"Am Rev Respir Dis"},{"key":"33_CR3","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1172\/JCI110344","volume":"68","author":"JE Gadek","year":"1981","unstructured":"Gadek JE, Fells GA, Zimmerman RL, et al.: Antielastases of the human alveolar structure: implications for the protease-antiprotease theory of emphysema. J Clin Invest 1981, 68:889\u2013898. This study formulated the prevailing theory for pathogenesis of emphysema.","journal-title":"J Clin Invest"},{"key":"33_CR4","first-page":"1504","volume":"24","author":"JH Teckman","year":"2000","unstructured":"Teckman JH, Qu D, Perlmutter DH: Molecular pathogenesis of liver disease in \u03b11-antitrypsin deficiency. Hepatology 1996, 24:1504\u20131516.","journal-title":"Hepatology"},{"key":"33_CR5","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/j.1651-2227.1988.tb10767.x","volume":"77","author":"T Sveger","year":"1995","unstructured":"Sveger T: The natural history of liver disease in alpha-1-antitrypsin deficient children. Acta Paediatr Scand 1995, 77:847\u2013851.","journal-title":"Acta Paediatr Scand"},{"key":"33_CR6","doi-asserted-by":"crossref","first-page":"9014","DOI":"10.1073\/pnas.91.19.9014","volume":"91","author":"Y Wu","year":"1994","unstructured":"Wu Y, Whitman I, Molmenti E, et al.: A lag in intracellular degradation of mutant \u03b11-antitrypsin correlates with the liver disease phenotype in homozygous PiZZ \u03b11-antitrypsin deficiency. Proc Natl Acad Sci U S A 1994, 91:9014\u20139018.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"33_CR7","first-page":"934","volume":"73","author":"HL Sharp","year":"1969","unstructured":"Sharp HL, Bridges RA, Krivit W: Cirrhosis associated with alpha-1-antitrypsin deficiency: a previously unrecognized inherited disorder. J Lab Clin Med 1969, 73:934\u2013939.","journal-title":"J Lab Clin Med"},{"key":"33_CR8","first-page":"68","volume":"57","author":"PL Hope","year":"1982","unstructured":"Hope PL, Hall MA, Millward-Sadler GH, Normand IC: Alpha-1-antitrypsin deficiency presenting as a bleeding diathesis in the newborn. Arch Dis Child 1982, 57:68\u201370.","journal-title":"Arch Dis Child"},{"key":"33_CR9","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0016-5085(83)90335-9","volume":"85","author":"FR Ghishan","year":"1983","unstructured":"Ghishan FR, Gray GF, Greene HL: \u03b11-antitrypsin deficiency presenting with ascites and cirrhosis in the neonatal period. Gastroenterology 1983, 85:435\u2013438.","journal-title":"Gastroenterology"},{"key":"33_CR10","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1056\/NEJM198603203141202","volume":"314","author":"S Eriksson","year":"1986","unstructured":"Eriksson S, Carlson J, Velez R: Risk of cirrhosis and primary liver cancer in alpha-1-antitrypsin deficiency. N Engl J Med 1986, 314:736\u2013739.","journal-title":"N Engl J Med"},{"key":"33_CR11","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0022-3476(83)80230-3","volume":"102","author":"G Nebbia","year":"1983","unstructured":"Nebbia G, Hadchouel M, Odievre M, Alagille D: Early assessment of evolution of liver disease associated with \u03b11-antitrypsin deficiency in childhood. J Pediatr 1983, 102:661\u2013665.","journal-title":"J Pediatr"},{"key":"33_CR12","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/S0022-3476(05)80123-4","volume":"117","author":"E Ibarguen","year":"1990","unstructured":"Ibarguen E, Gross CR, Savik SK, Sharp HL: Liver disease in \u03b11-antitrypsin deficiency: prognostic indicators. J Pediatr 1990, 117:864\u2013870.","journal-title":"J Pediatr"},{"key":"33_CR13","unstructured":"Volpert D, Molleston JP, Perlmutter DH: Alpha-1-antitrypsin deficiency-associated liver disease may progress slowly in some children. J Ped Gastro Nutr, In press."},{"key":"33_CR14","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJM198103053041001","volume":"304","author":"JR Hodges","year":"1981","unstructured":"Hodges JR, Millward Sadler GH, Barbatis C, Wright R: Heterozygous MZ \u03b11-antitrypsin deficiency in adults with chronic active hepatitis and cryptogenic cirrhosis. N Engl J Med 1981, 304:357\u2013360.","journal-title":"N Engl J Med"},{"key":"33_CR15","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/hep.510280421","volume":"28","author":"IW Graziadei","year":"1998","unstructured":"Graziadei IW, Joseph JJ, Wiesner RH, et al.: Increased risk of chronic liver failure in adults with heterozygous \u03b11-antitrypsin deficiency. Hepatology 1998, 28:1058\u20131063.","journal-title":"Hepatology"},{"key":"33_CR16","doi-asserted-by":"crossref","first-page":"641","DOI":"10.7326\/0003-4819-117-8-641","volume":"117","author":"T Propst","year":"1992","unstructured":"Propst T, Propst A, Dietze O, et al.: High prevalence of viral infections in adults with homozygous and heterozygous \u03b11-antitrypsin deficiency and chronic liver disease. Ann Intern Med 1992, 117:641\u2013645.","journal-title":"Ann Intern Med"},{"key":"33_CR17","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/ajcp\/79.6.697","volume":"79","author":"A Qizibash","year":"1983","unstructured":"Qizibash A, Yong-Pong O: Alpha-1-antitrypsin liver disease: differential diagnosis of PAS-positive diastase-resistant globules in liver cells. Am J Clin Pathol 1983, 79:697\u2013702.","journal-title":"Am J Clin Pathol"},{"key":"33_CR18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.0954-6820.1978.tb08452.x","volume":"204","author":"C Larsson","year":"1978","unstructured":"Larsson C: Natural history and life expectancy in severe alpha-1-antitryspin deficiency, PiZZ. Acta Med Scand 1978, 204:345\u2013351.","journal-title":"Acta Med Scand"},{"key":"33_CR19","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0140-6736(85)91916-6","volume":"I","author":"ED Janus","year":"1985","unstructured":"Janus ED, Phillips NT, Carrell RW: Smoking, lung function and alpha-1-antitrypsin deficiency. Lancet 1985, I:152\u2013154.","journal-title":"Lancet"},{"key":"33_CR20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0007-0971(83)90002-5","volume":"77","author":"MJ Tobin","year":"1983","unstructured":"Tobin MJ, Cook PJL, Hutchison DCS: Alpha-1-antitrypsin deficiency: the clinical and physiological features of pulmonary emphysema in subjects homozygous for Pi type Z. Br J Dis Chest 1983, 77:14\u201327.","journal-title":"Br J Dis Chest"},{"key":"33_CR21","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0168-8278(05)80614-2","volume":"21","author":"FA Casavilla","year":"1994","unstructured":"Casavilla FA, Reyes J, Tzakis A, et al.: Liver transplantation for neonatal hepatitis as compared to the other two leading indications for liver transplantation in children. Hepatol 1994, 21:1035\u20131039.","journal-title":"Hepatol"},{"key":"33_CR22","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/S0022-3476(05)80123-4","volume":"117","author":"TE Starzl","year":"1990","unstructured":"Starzl TE, Porter KA, Busuttil RW, et al.: Liver disease in alpha-1-antitrypsin deficiency: prognostic indicators. J Pediatr 1990, 117:864\u2013870.","journal-title":"J Pediatr"},{"key":"33_CR23","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/0016-5085(86)90860-7","volume":"90","author":"V Cuervas-Mons","year":"1986","unstructured":"Cuervas-Mons V, Rinola A, Van Thiel DH, et al.: Does previous abdominal surgery alter the outcome of pediatric patients subjected to orthotopic liver transplantation? Gastroenterology 1986, 90:853\u20138857.","journal-title":"Gastroenterology"},{"key":"33_CR24","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1074\/jbc.271.2.635","volume":"271","author":"S Sato","year":"2000","unstructured":"Sato S, Ward CL, Krouse ME, et al.: Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation. J Biol Chem 1996, 271:635\u2013638.","journal-title":"J Biol Chem"},{"key":"33_CR25","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1172\/JCI119302","volume":"99","author":"CR Brown","year":"1997","unstructured":"Brown CR, Hong-Brown LQ, Welch WJ: Correcting temperature-sensitive protein folding defects. J Clin Invest 1997, 99:1432\u20131444.","journal-title":"J Clin Invest"},{"key":"33_CR26","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/4801","volume":"5","author":"J-Q Fan","year":"1999","unstructured":"Fan J-Q, Ishii S, Asano N, Suzuki Y: Accelerated transport and maturation of lysosomal alphagalactosidase A in Fabry lymphoblasts by an enzyme inhibitor. Nat Med 1999, 5:112\u2013115.","journal-title":"Nat Med"},{"key":"33_CR27","doi-asserted-by":"crossref","first-page":"34825","DOI":"10.1074\/jbc.274.49.34825","volume":"274","author":"BK Tamarappoo","year":"1999","unstructured":"Tamarappoo BK, Yang B, Verkman AS: Misfolding of mutant aquaporin-2 water channels in nephrogenic diabetes insipidus. J Biol Chem 1999, 274:34825\u201334831.","journal-title":"J Biol Chem"},{"key":"33_CR28","doi-asserted-by":"crossref","first-page":"32970","DOI":"10.1074\/jbc.274.46.32970","volume":"274","author":"D-S Yang","year":"1999","unstructured":"Yang D-S, Yip CM, Huang THJ, et al.: Manipulating the amyloid-b aggregation pathway with chemical chaperones. J Biol Chem 1999, 274:32970\u201332974.","journal-title":"J Biol Chem"},{"key":"33_CR29","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1172\/JCI8688","volume":"105","author":"J-P Morello","year":"2000","unstructured":"Morello J-P, Salahpour A, Laperriere A, et al.: Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants. J Clin Invest 2000, 105:887\u2013895.","journal-title":"J Clin Invest"},{"key":"33_CR30","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1172\/JCI9158","volume":"105","author":"WJ Welch","year":"2000","unstructured":"Welch WJ, Howard M: Antagonists to the rescue. J Clin Invest 2000, 105:853\u2013854.","journal-title":"J Clin Invest"},{"key":"33_CR31","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1073\/pnas.97.4.1796","volume":"97","author":"JAJ Burrows","year":"2000","unstructured":"Burrows JAJ, Willis LK, Perlmutter DH: Chemical chaperones mediate increased secretion of mutant \u03b11-antitrypsin (\u03b11-AT) Z. A potential pharmacological strategy for prevention of liver injury and emphysema in \u03b11-AT deficiency. Proc Natl Acad Sci U S A 2000, 97:1796\u20131801. Description of a novel pharmacologic strategy for prevention of liver disease and emphysema in \u03b11AT deficiency.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"33_CR32","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1074\/jbc.275.3.1987","volume":"275","author":"NY Marcus","year":"2000","unstructured":"Marcus NY, Perlmutter DH: Glucosidase and mannosidase inhibitors mediate increased secretion of mutant \u03b11-antitrypsin Z. J Biol Chem 2000, 275:1987\u20131992.","journal-title":"J Biol Chem"},{"key":"33_CR33","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/0959-440X(95)80051-4","volume":"5","author":"GS Jacob","year":"1995","unstructured":"Jacob GS: Glycosylation inhibitors in biology and medicine. Curr Opin Struct Biol 1995, 5:605\u2013611.","journal-title":"Curr Opin Struct Biol"},{"key":"33_CR34","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI114578","volume":"95","author":"RG Crystal","year":"1990","unstructured":"Crystal RG: Alpha-1-antitrypsin deficiency, emphysema and liver disease: genetic basis and strategies for therapy. J Clin Invest 1990, 95:1343\u20131352.","journal-title":"J Clin Invest"},{"key":"33_CR35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1164\/ajrccm.158.1.9712017","volume":"158","author":"The Alpha-1-Antitrypsin Deficiency Registry Study Group","year":"1998","unstructured":"The Alpha-1-Antitrypsin Deficiency Registry Study Group: Survival and FEV1 decline in individuals with severe deficiency of \u03b11-antitrypsin. Am J Respir Crit Care Med 1998, 158:49\u201359.","journal-title":"Am J Respir Crit Care Med"},{"key":"33_CR36","doi-asserted-by":"crossref","first-page":"284S","DOI":"10.1378\/chest.110.6_Supplement.284S","volume":"110","author":"EP Trulock","year":"2000","unstructured":"Trulock EP: Lung transplantation for \u03b11-antitrypsin deficiency emphysema. Chest 1996, 110:284S-294S.","journal-title":"Chest"},{"key":"33_CR37","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/32801","volume":"392","author":"WF Anderson","year":"1998","unstructured":"Anderson WF: Human gene therapy. Nature 1998, 392:25\u201330.","journal-title":"Nature"},{"key":"33_CR38","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1126\/science.280.5369.1593","volume":"280","author":"N Lan","year":"1998","unstructured":"Lan N, Howrey RP, Lee S-W, et al.: Ribozyme-mediated repair of sickle b-globin mRNAs in erythrocyte precursors. Science 1998, 280:1593\u20131596.","journal-title":"Science"},{"key":"33_CR39","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nm0398-285","volume":"4","author":"BT Kren","year":"1998","unstructured":"Kren BT, Bandyopadhyay P, Steer CJ: In vivo sitedirected mutagenesis of the factor IX gene by chimeric RNA\/DNA oligonucleotides. Nat Med 1998, 4:285\u2013290. One of the critical papers describing the use of chimeric RNA\/DNA oligonucleotides for correction of a genetic defect of the liver.","journal-title":"Nat Med"},{"key":"33_CR40","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1126\/science.8108734","volume":"263","author":"JA Rhim","year":"1994","unstructured":"Rhim JA, Sandgen EP, Degen JL, Brinster RL: Replacement of disease mouse liver by hepatic cell transplantation. Science 1994, 263:1149\u20131152. This study formed the basis of hepatocyte transplantation for treatment of liver disease.","journal-title":"Science"},{"key":"33_CR41","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/ng0396-266","volume":"12","author":"K Overturf","year":"2000","unstructured":"Overturf K, Al-Dhalimy M, Tanguay R, et al.: Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I. Nat Gene 1996, 12:266\u2013273.","journal-title":"Nat Gene"},{"key":"33_CR42","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1006\/jmbi.1997.1458","volume":"275","author":"PR Elliott","year":"1998","unstructured":"Elliott PR, Abrahams J-P, Lomas DA: Wild-type \u03b11-antitrypsin is in the cannonical inhibitory conformation. J Mol Biol 1998, 275:419\u2013425.","journal-title":"J Mol Biol"},{"key":"33_CR43","doi-asserted-by":"crossref","first-page":"8064","DOI":"10.1073\/pnas.94.15.8064","volume":"94","author":"PM Day","year":"1997","unstructured":"Day PM, Yewdell JW, Porgador A, et al.: Direct delivery of exogenous MHC class I molecule-binding oligopeptides to the endoplasmic reticulum of viable cells. Proc Natl Acad Sci USA 1997, 94:8064\u20138069.","journal-title":"Proc Natl Acad Sci USA"},{"key":"33_CR44","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0962-8924(97)01209-9","volume":"8","author":"L Johannes","year":"1998","unstructured":"Johannes L, Goud B: Surfing on a retrograde wave: how does Shiga toxin reach the endoplasmic reticulum? Trends Cell Biol 1998, 8:158\u2013162.","journal-title":"Trends Cell Biol"},{"key":"33_CR45","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1083\/jcb.140.4.733","volume":"140","author":"JM Lord","year":"1998","unstructured":"Lord, JM, Roberts LM: Toxin entry: retrograde transport through the secretory pathway. J Cell Biol 1998, 140:733\u2013736.","journal-title":"J Cell Biol"}],"container-title":["Current Treatment Options in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-000-0033-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11938-000-0033-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-000-0033-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T13:49:53Z","timestamp":1587563393000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11938-000-0033-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,12]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2000,12]]}},"alternative-id":["33"],"URL":"https:\/\/doi.org\/10.1007\/s11938-000-0033-8","relation":{},"ISSN":["1092-8472","1534-309X"],"issn-type":[{"value":"1092-8472","type":"print"},{"value":"1534-309X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,12]]}}}